使用层次分类的生物开发能力数据分析加速了候选选,优化和预制选
Kevin James Metcalf1, Galen Wo2, Jan Paulo Zaragoza1
1Discovery Biologics, Merck & Co. Inc, Rahway, NJ, USA.
mAbs
|May 10, 2025
概括
层次聚类分析通过使用高通量可开发性数据高效排名蛋白质候选物来简化生物药物开发. 这种数据驱动的方法加速了生物制剂的选和预制剂选.
科学领域:
- 生物技术是生物技术.
- 蛋白质工程是指蛋白质工程.
- 药物发现 药物发现 药物发现
背景情况:
- 选择最佳蛋白序列对于成功的生物药物开发至关重要.
- 高通量开发能力评估根据生物物理性质对强有力的分子进行排名.
- 对大量分子数据的手动分析是耗时且容易出现错误的.
研究的目的:
- 为生物制剂的数据驱动的选提供分层聚类分析.
- 将这种方法应用于使用高通量可开发性数据的预配方选.
- 简化,精简和加速生物发现和早期开发.
主要方法:
- 对高通量可开发性数据应用了层次聚类分析.
- 该方法用于优先考虑抗体模式,包括双特异性抗体和单克隆性抗体.
- 应用包括格式和链条配对,序列优化和预制选.
主要成果:
- 层次聚类有效地根据可开发性和预制剂性质对分子进行排序.
- 这项分析有助于在各种抗体格式和优化策略中确定优先级.
- 这种方法证明了选择过程的实质性简化和加速.
结论:
- 层次聚类分析为生物选择提供了一个强大的,数据驱动的方法.
- 高通量方法提高了用于临床前和临床开发的分子排名效率.
- 这种方法极大地简化了生物发现和开发的早期阶段.
相关概念视频
Drug Discovery: Overview
13.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
565
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
565
Drug Products: Biologics, Biosimilars and Interchangeables
358
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
358
Biopharmaceutical Factors Influencing Drug Product Design: Overview
502
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
502
Upstream Processing
87
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
87


